ey0016.3-9 | Congenital Hypothyroidism | ESPEYB16
C Saba , S Guilmin-Crepon , D Zenaty , L Martinerie , A Paulsen , D Simon , C Storey , S Dos Santos , J Haignere , D Mohamed , JC Carel , J Leger
ey0018.1-12 | Clinical/Translational | ESPEYB18
M Shareef , MP Nasrallah , N AlArab , LA Atweh , C Zadeh , R Hourani
ey0018.2-2 | Neonatal hypoglycaemia | ESPEYB18
C Nava , A Modiano Hedenmalm , F Borys , L Hooft , M Bruschettini , K Jenniskens
ey0018.2-23 | Miscellaneous | ESPEYB18
SN Walley , EA Krumm , A Yasrebi , J Kwiecinski , V Wright , C Baker , TA Roepke
ey0018.6-10 | Patient Related Outcomes | ESPEYB18
Duranteau Lise , Rapp Marion , van de Grift Tim C , Hirschberg Angelica L
ey0018.7-5 | Clinical Guidance | ESPEYB18
EV Brauner , AS Busch , C Eckert-Lind , T Koch , M Hickey , A Juul
ey0018.9-1 | Cancer treatment and the risk of second neoplasia | ESPEYB18
NMY Journy , WS Zrafi , S Bolle , B Fresneau , C Alapetite , RS Allodji , D Berchery , N Haddy , I Kobayashi , M Labbe , H Pacquement , C Pluchart , B Schwartz , V Souchard , C Thomas-Teinturier , C Veres , G Vu-Bezin , I Diallo , F de Vathaire
ey0018.9-12 | Cancer treatment, growth and growth hormone therapy | ESPEYB18
SR Rose , M Carlsson , A Grimberg , F Aydin , A Albanese , ACS Hokken-Koelega , C Camacho-Hubner
ey0018.10-11 | (1) | ESPEYB18
H Thabit , JN Prabhu , W Mubita , C Fullwood , S Azmi , A Urwin , I Doughty , L Leelarathna
ey0018.12-7 | Type 2 Diabetes | ESPEYB18
RA Delicano , U Hammar , A Egenvall , C Westgarth , M Mubanga , L Byberg , T Fall , B Kennedy